Delta Infection After Vaccination Elicits Potent Neutralizing Immunity Against Severe Acute Respiratory Syndrome Coronavirus 2 Omicron

被引：3

作者：

Zhu, Ka-Li ^{[1
,2
]}

Gao, Hui-Xia ^{[3
]}

Yao, Lin ^{[2
]}

Rong, Jun ^{[3
]}

Yang, Li ^{[3
]}

Zhang, Zhi ^{[3
]}

Jiang, Ping ^{[3
]}

Duan, Li-Jun ^{[2
]}

Wang, Guo-Lin ^{[2
]}

Dai, Er-Hei ^{[3
]}

Ma, Mai-Juan ^{[1
,2
]}

机构：

[1] Anhui Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Hefei, Peoples R China

[2] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, 20 Dongda St, Beijing 100071, Peoples R China

[3] Hebei Med Univ, Hosp Shijiazhuang 5, Shijiazhuang, Hebei, Peoples R China

来源：

JOURNAL OF INFECTIOUS DISEASES | 2022年 / 226卷 / 09期

基金：

北京市自然科学基金;

关键词：

SARS-CoV-2; Delta infection; Omicron; vaccination; neutralization;

D O I：

10.1093/infdis/jiac149

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron (B.1.1.529) variant extensively escape neutralizing antibodies by vaccines or infection. We assessed serum neutralizing activity in sera from Delta infection after vaccination and Delta infection only against SARS-CoV-2 Wuhan-Hu-1 (WA1), Beta, Delta, and Omicron. Sera from Delta infection only could neutralize WA1 and Delta but almost completely lost capacity to neutralize Beta and Omicron. However, Delta infection after vaccination resulted in a significant increase of serum neutralizing activity against WA1, Beta, and Omicron. This study demonstrates that breakthrough infection of Delta substantially induced high potency humoral immune response against the Omicron variant and other emerged variants. The sera from patients with the Delta infection only had less neutralizing activity to the Omicron, whereas the sera from patients with Delta infection after vaccination displayed potent neutralization to the Omicron variant.

引用

页码：1551 / 1555

页数：5

共 50 条

[31] Effectiveness of first-generation severe acute respiratory syndrome coronavirus 2 mRNA vaccines against the Omicron variant [J].

Dagan, Noa ;

Barda, Noam .

CLINICAL MICROBIOLOGY AND INFECTION, 2022, 28 (12) :1526-1527

[32] Prevalence of Adenopathy at Chest Computed Tomography After Vaccination for Severe Acute Respiratory Syndrome Coronavirus 2 [J].

McGuinness, Georgeann ;

Alpert, Jeffrey B. ;

Brusca-Augello, Geraldine ;

Azour, Lea ;

Ko, Jane P. ;

Tamizuddin, Farah ;

Gozansky, Elliott K. ;

Moore, William H. .

JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, 2023, 47 (01) :50-57

[33] Absence of Severe Acute Respiratory Syndrome Coronavirus 2 Neutralizing Activity in Prepandemic Sera From Individuals With Recent Seasonal Coronavirus Infection [J].

Poston, Daniel ;

Weisblum, Yiska ;

Wise, Helen ;

Templeton, Kate ;

Jenks, Sara ;

Hatziioannou, Theodora ;

Bieniasz, Paul .

CLINICAL INFECTIOUS DISEASES, 2021, 73 (05) :E1208-E1211

[34] Commercial Immunoglobulin Products Contain Neutralizing Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein [J].

Upasani, Vinit ;

Townsend, Katie ;

Wu, Mary Y. ;

Carr, Edward J. ;

Hobbs, Agnieszka ;

Dowgier, Giulia ;

Ragno, Martina ;

Herman, Lou S. ;

Sharma, Sonal ;

Shah, Devesh ;

Lee, Simon F. K. ;

Chauhan, Neil ;

Glanville, Julie M. ;

Neave, Lucy ;

Hanson, Steven ;

Ravichandran, Sriram ;

Tynan, Aoife ;

O'Sullivan, Mary ;

Moreira, Fernando ;

Workman, Sarita ;

Symes, Andrew ;

Burns, Siobhan O. ;

Tadros, Susan ;

Hart, Jennifer C. L. ;

Beale, Rupert C. L. ;

Gandhi, Sonia ;

Wall, Emma C. ;

Mccoy, Laura ;

Lowe, David M. .

CLINICAL INFECTIOUS DISEASES, 2023, 77 (07) :950-960

[35] Mucosal and Systemic Responses to Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination Determined by Severity of Primary Infection [J].

Sajadi, Mohammad M. ;

Myers, Amber ;

Logue, James ;

Saadat, Saman ;

Shokatpour, Narjes ;

Quinn, James ;

Newman, Michelle ;

Deming, Meagan ;

Tehrani, Zahra Rikhtegaran ;

Magder, Laurence S. ;

Karimi, Maryam ;

Abbasi, Abdolrahim ;

Shlyak, Mike ;

Baracco, Lauren ;

Frieman, Matthew B. ;

Crotty, Shane ;

Harris, Anthony D. .

MSPHERE, 2022, 7 (06)

[36] An evolutionary insight into Severe Acute Respiratory Syndrome Coronavirus 2 Omicron variant of concern. [J].

Paz, Mercedes ;

Aldunate, Fabian ;

Arce, Rodrigo ;

Ferreiro, Irene ;

Cristina, Juan .

VIRUS RESEARCH, 2022, 314

[37] Low Levels of Neutralizing Antibodies After Natural Infection With Severe Acute Respiratory Syndrome Coronavirus 2 in a Community-Based Serological Study [J].

McDade, Thomas W. ;

Sancilio, Amelia ;

D'Aquila, Richard ;

Mustanski, Brian ;

Vaught, Lauren A. ;

Reiser, Nina L. ;

Velez, Matthew E. ;

Hsieh, Ryan R. ;

Ryan, Daniel T. ;

Saber, Rana ;

McNally, Elizabeth M. ;

Demonbreun, Alexis R. .

OPEN FORUM INFECTIOUS DISEASES, 2022, 9 (03)

[38] Coronavirus disease 2019 transmission and symptoms in young children during the severe acute respiratory syndrome coronavirus 2 Delta variant and Omicron variant outbreaks [J].

Akaishi, Tetsuya ;

Ishii, Tadashi .

JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2022, 50 (05)

[39] Longitudinal Neutralizing and Functional Antibody Responses to Severe Acute Respiratory Syndrome Coronavirus 2 Variants Following Messenger RNA Coronavirus Disease 2019 Vaccination [J].

Chen, Xuemin ;

Ciric, Caroline ;

Gibson, Theda ;

Anderson, Larry J. ;

Anderson, Evan J. ;

Rostad, Christina A. .

OPEN FORUM INFECTIOUS DISEASES, 2023, 10 (04)

[40] Exacerbation of Autoimmune Bullous Diseases After Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination: Is There Any Association? [J].

Kianfar, Nika ;

Dasdar, Shayan ;

Salehi Farid, Ali ;

Balighi, Kamran ;

Mahmoudi, Hamidreza ;

Daneshpazhooh, Maryam .

FRONTIERS IN MEDICINE, 2022, 9

← 1 2 3 4 5 →